Falkner; Falko-Gunter

Patent Applications and Registrations

Patent applications and USPTO patent grants for Falkner; Falko-Gunter.The latest application filed is for "viral vectors encoding recombinant fviii variants with increased expression for gene therapy of hemophilia a".

Company Profile

1.12.12

Falkner; Falko-Gunter - Orth/Donau AT
Falkner; Falko-Gunter - Orth AT
Falkner; Falko Gunter - Mannsdorf AT
Falkner; Falko-Gunter - Vienna AT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Viral Vectors Encoding Recombinant Fviii Variants With Increased Expression For Gene Therapy Of Hemophilia A App 20220213172 - Falkner; Falko-Gunter ; et al.	2022-07-07
Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A Grant 11,254,731 - Falkner , et al. February 22, 2	2022-02-22
Viral Vectors Encoding Recombinant Fix With Increased Expression For Gene Therapy Of Hemophilia B App 20210128700 - Horling; Franziska ; et al.	2021-05-06
Viral vectors encoding recombinant fix with increased expression for gene therapy of hemophilia B Grant 10,842,853 - Horling , et al. November 24, 2	2020-11-24
Viral Vectors Encoding Recombinant Fviii Variants With Increased Expression For Gene Therapy Of Hemophilia A App 20190202893 - Falkner; Falko-Gunter ; et al.	2019-07-04
Viral Vectors Encoding Recombinant Fviii Variants With Increased Expression For Gene Therapy Of Hemophilia A App 20190194295 - Falkner; Falko-Gunter ; et al.	2019-06-27
Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza A viruses Grant 10,329,583 - Falkner , et al.	2019-06-25
Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A Grant 10,189,889 - Falkner , et al. Ja	2019-01-29
Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A Grant 10,189,888 - Falkner , et al. Ja	2019-01-29
Viral Vectors Encoding Recombinant Fix With Increased Expression For Gene Therapy Of Hemophilia B App 20180339026 - Horling; Franziska ; et al.	2018-11-29
Viral Vectors Encoding Recombinant Fviii Variants With Increased Expression For Gene Therapy Of Hemophilia A App 20170233455 - Falkner; Falko-Gunter ; et al.	2017-08-17
Viral Vectors Encoding Recombinant Fviii Variants With Increased Expression For Gene Therapy Of Hemophilia A App 20170226188 - Falkner; Falko-Gunter ; et al.	2017-08-10
Recombinant Viral Vectors And Methods For Inducing A Heterosubtypic Immune Response To Influenza A Viruses App 20170121735 - FALKNER; Falko-Gunter ; et al.	2017-05-04
Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza A viruses Grant 9,463,237 - Falkner , et al. October 11, 2	2016-10-11
Recombinant Viral Vectors And Methods For Inducing An Immune Response To Yellow Fever Virus App 20140255440 - Falkner; Falko-Gunter ; et al.	2014-09-11
Recombinant Viral Vectors And Methods For Inducing A Heterosubtypic Immune Response To Influenza A Viruses App 20140050759 - Falkner; Falko-Gunter ; et al.	2014-02-20
Recombinant Viral Vectors and Methods for Inducing an Immune Response to Yellow Fever Virus App 20120328649 - Falkner; Falko-Gunter ; et al.	2012-12-27
Direct molecular cloning of foreign genes into poxviruses and methods for the preparation of recombinant proteins Grant 6,265,183 - Dorner , et al. July 24, 2	2001-07-24
Methods for generating immune responses employing modified vaccinia of fowlpox viruses Grant 6,103,244 - Dorner , et al. August 15, 2	2000-08-15
Prothrombin derivatives Grant 6,086,871 - Fischer , et al. July 11, 2	2000-07-11
Recombinant poxviruses with foreign DNA in essential regions Grant 5,770,212 - Falkner , et al. June 23, 1	1998-06-23
recombinant poxviruses with foreign DNA in essential regions Grant 5,766,882 - Falkner , et al. June 16, 1	1998-06-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.